New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

May 31, 2004

Conditions
Bacterial Infections
Interventions
DRUG

Zyvox® / Linezolid

Trial Locations (21)

10021

Research Center, New York

10029

Research Center, New York

10032

Research Center, New York

17822

Research Center, Danville

19104

Research Center, Philadelphia

20010

Research Center, Washington D.C.

21287

Research Center, Baltimore

30342

Research Center, Atlanta

32610

Research Center, Gainesville

40202

Research Center, Louisville

44195

Research Center, Cleveland

48201

Research Center, Detroit

60068

Research Center, Park Ridge

60614

Research Center, Chicago

78701

Research Center, Austin

90027

Research Center, Los Angeles

90095

Research Center, Los Angeles

90806

Research Center, Long Beach

06106

Research Center, Hartford

02111

Research Center, Boston

08103

Research Center, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY